Replies to post #14009 on Biotech Values

[DewDiligence]

CABG down 30%, and it could have been (and may yet be) much worse. I think the company’s raison d’etre is now in question.

[Praveen]

CABG & EVVV---hi Dew n Board

As i have expressed my concern about CABG's technology and it being a one trick pony, I didn't feel right about it in my heart. I don't have a position in them. I will still watch them in the future.

EVVV is a new IPO in bio. I am just looking into them.They have interesting products. Does anyone follow them?

TIA,
Praveen